Related Experiment Video
Updated: Jun 24, 2025

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Enfortumab Vedotin Drug Eruption: Cutaneous Adverse Events and Histopathologic Findings
Fiore Casale1, Gretchen Roth1, Karolyn Wanat1
1Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI; and.
Enfortumab vedotin (EV) can cause skin reactions like toxic erythema due to nectin-4 expression in the skin. These chemotherapy side effects are often manageable with topical treatments, aiding in continued cancer therapy.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Enfortumab vedotin (EV) is an antibody-drug conjugate targeting nectin-4 for urothelial cancers.
- Cutaneous side effects are common with EV due to nectin-4 expression in the skin.
- Histologic findings can help identify drug-induced eruptions and guide management.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Related Concept Videos
Allergic Drug Reactions
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Applications of Epidermal Stem Cells